Immunosuppressive treatment of severe acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Transplant Proc. 2002 Nov;34(7):2931-3. doi: 10.1016/s0041-1345(02)03493-0.

Authors

I P Zupan¹, S Zver, J Pretnar

Affiliation

¹ Department of Haematology, University Medical Centre Ljubljana, Ljubljana, Slovenia. irena.zupan@kclj.si

PMID: 12431662
DOI: 10.1016/s0041-1345(02)03493-0

No abstract available

MeSH terms

Adolescent
Adult
Female
Graft vs Host Disease / drug therapy*
Graft vs Host Disease / immunology*
Graft vs Host Disease / prevention & control
Hematopoietic Stem Cell Transplantation / adverse effects*
Hodgkin Disease / therapy
Humans
Immunosuppressive Agents / therapeutic use*
Leukemia / therapy
Male
Middle Aged
Multiple Myeloma / therapy
Primary Myelofibrosis / therapy
Retrospective Studies
Transplantation, Homologous / adverse effects
Transplantation, Homologous / immunology

Substances

Immunosuppressive Agents